Transversus Abdominis Plane Block Versus Erector Spinae Plane Block
Ultrasound Guided Transversus Abdominis Plane Block Versus Erector Spinae Plane Block in Patients Undergoing Emergency Laparotomies.
1 other identifier
interventional
100
1 country
1
Brief Summary
The TAP block, first described by Rafi in 2001, is comprised of deposition of a local anesthetic into the anatomical plane between the internal oblique and transverses abdominis muscles, where thess thoracoabdominal nerves (T6-L1) contribute to the main sensory supply of the skin, muscles, and parietal peritoneum of the anterior abdominal wall. These nerves branch and communicate extensively with each other in the TAP . Erector spinae plane (ESP) block is a recently described interfascial block in which the local anaesthectic is placed over or below the plane of the erector spinae muscle, near where the spinal nerves come out from the spine before they start to divide. Some publications have shown its effectiveness in treating thoracic and abdominal postoperative pain. Postoperative pain is the major obstacle for early postoperative ambulation and increases the risk of venous thromboembolism, respiratory complications and prolongs the hospital stay. Parietal pain is the chief component of postoperative pain after abdominal surgeries. Large doses of opioids are required to mitigate this pain, but they are poorly tolerated. Multimodal analgesia is effective in handling postoperative pain and in attenuating the side effects of large doses of a single analgesic .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable postoperative-pain
Started May 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2019
CompletedStudy Start
First participant enrolled
May 15, 2019
CompletedFirst Posted
Study publicly available on registry
June 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 12, 2020
CompletedResults Posted
Study results publicly available
March 25, 2020
CompletedJune 30, 2020
June 1, 2020
9 months
May 4, 2019
February 11, 2020
June 18, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Time of First Post Operative Analgesic Request
the pain will be assisted based on the time for the first dose of rescue analgesia
24 hours
Postoperative Total Fentanyl Requirement
The total amount of postoperative fentanyl in milligram was given to the patient as rescue analgesia during 24 hours
24 hours
Secondary Outcomes (1)
Incidence of Any Adverse Events
5 days
Study Arms (3)
Group I (A group)
EXPERIMENTAL31 patients Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side).
Group II (B group)
ACTIVE COMPARATOR31patients Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side).
Group III (C group)
PLACEBO COMPARATOR31 patients anesthetized with the protocol followed by Minia University Hospital
Interventions
The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected
The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes
Eligibility Criteria
You may qualify if:
- \. Age18-70 . 2. Both gender . 3 .Emergency laparotomies . 4. ASA I-III .
You may not qualify if:
- Drug allergy .
- Morbid obesity (BMI \>40 kg/m2) .
- Psychiatric disorder .
- Opioid dependence .
- patient refuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Minia University Hospital
Minya, 61511, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Hassan Elshorbagy
- Organization
- Minia university
Study Officials
- STUDY CHAIR
Nagy S. Ali, MD
Minia University Hospital
- STUDY DIRECTOR
Abeer A Hassanien
Minia University Hospital
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- assistant lecture
Study Record Dates
First Submitted
May 4, 2019
First Posted
June 18, 2019
Study Start
May 15, 2019
Primary Completion
February 1, 2020
Study Completion
February 12, 2020
Last Updated
June 30, 2020
Results First Posted
March 25, 2020
Record last verified: 2020-06